Discover B2B leads for Pharmaceuticals industry
Identify and research relevant prospects for B2B lead generation on Pharmaceuticals sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 33 in our database
Found 263 in our records
HQ: Temple City, California, United States
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
HQ: Temple City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
17 Emails
1 Phones
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Lawrence Weiss
l****s@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Alex Witterschein
a**************n@fulgentgenetics.com
-
Erin Heaney
e*****y@fulgentgenetics.com
-
Eric Chen
e******n@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com
HQ: Northbrook, Illinois, United States
Horizon Pharma
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
HQ: Northbrook, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
14 Emails
1 Phones
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
Shvetali Thatte
s*************e@horizontherapeutics.com.If
2**********0
-
Tina Ventura
t**********a@horizontherapeutics.com
-
Lou Scerbo
l*****o@horizontherapeutics.com
-
Maria Tello
m****o@horizontherapeutics.com
-
Randall Schenck
r*************k@horizontherapeutics.com
-
Paul Vanek
p********k@horizontherapeutics.com
-
Anne O'Donnell
a*******l@horizontherapeutics.com
-
Todd Smith
t****h@horizontherapeutics.com
-
James Inglis
j*****s@horizontherapeutics.com
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com
HQ: New York, New York, United States
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
HQ: Bothell, Washington, United States
Seagen
Seagen is a clinical-stage biotechnology company dShow more...edicated to improving patient outcomes with advanced antibody-drug conjugate technology.
HQ: Bothell, Washington, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@seagen.com (83.3%)
-
Guy Padbury
Senior Vice President, Translational Sciences
g******y@seagen.com
-
Bryce Mansfield
Executive Director, R&D Quality
b********d@seagen.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k*****i@seagen.com
-
Davina Sparks Henderson
Sr Manager. Field Reimbursement
d********n@seagen.com
-
Virginie Oble Bouvet
v***e@seagen.com
-
Peter Senter
VP, Chemistry,VP, Distinguished Research Fellow
p***r@seagen.com
-
Marcel Koopman
International Product Manager Oncology
m******n@seagen.com
-
Jayeshkumar Soneji
j*****i@seagen.com
-
General Inquiries
contact@seagen.com
HQ: Castres-gironde, Aquitaine, France
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
HQ: Castres-gironde, Aquitaine, France
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
HQ: Morrisville, North Carolina, United States
Syneos Health
Syneos Health, the only fully integrated end-to-enShow more...d clinical and commercial solution organization.
HQ: Morrisville, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Last Investment Activity: Jan 12, 2024
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@syneoshealth.com (100.0%)
-
Ian Dorrian
President Communications Europe
i*********n@syneoshealth.com
-
Sean Wallace
Clinical Technician
s**********e@syneoshealth.com
-
Elgin C Duckery
District Sales Manager
e***********y@syneoshealth.com
-
Aparna Sree
Talent Acquisition Spec II
a******p@syneoshealth.com
-
Agnieszka Mazek
International Corporate Recruiter II
a*************k@syneoshealth.com
-
Career Opportunities
jobs@syneoshealth.com
-
Unclassified inbox
abcdefghij@syneoshealth.com
-
Unclassified inbox
toby.marshall@syneoshealth.com
HQ: Hamburg, Hamburg, Germany
Evotec
Evotec is a pharmaceutical and life science companShow more...y that provides drug discovery and gene therapy solutions.
HQ: Hamburg, Hamburg, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:EVO
Operating Status: Active
5 Emails
0 Phones
Main email format: sarah.smith@evotec.com (75.0%)
-
Benedict Chen
Vice President
b***********n@evotec.com
-
Alessandro Orsetti
a****************i@evotec.com
-
Alex Jakober
Sr Systems Engineer
a**********r@evotec.com
-
Christopher W.
IT Group Leader Site Services
c***********w@evotec.com
-
General Inquiries
info@evotec.com
HQ: Dublin, Dublin, Ireland
Shire
Shire biotechnology company that focuses on servinShow more...g people with rare diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics, Wellness
Acquired by: Takeda
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: May 14, 2024
Founded Date: 1986
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:SHPG
Operating Status: Closed
9 Emails
0 Phones
Main email format: ssmith@shire.com (100.0%)
-
Katelyn Mallozzi
Head of Global Planning and Design
k*******i@shire.com
-
Scott Donald
UK Head of Neuroscience
s*****d@shire.com
-
Nirvan Hulangamuwa
Finance Business Partner
n**********a@shire.com
-
Victor Otcheretko
v*********o@shire.com
-
General Inquiries
info@shirehousing.com
-
General Inquiries
info@shirefoods.com
-
Unclassified inbox
golf@theshirelondon.com
-
Unclassified inbox
shire@woodanilling.wa.gov.au
-
Unclassified inbox
abcdefghij@shire.com
HQ: San Diego, California, United States
Rakuten Medical
Rakuten Medical is a biotechnology company that deShow more...velops precision, cell-targeting investigational therapies.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Series E
Last Investment Activity: Mar 26, 2024
Founded Date: 2010
Company Type: For Profit
Operating Status: Active
6 Emails
0 Phones
Main email format: ssmith@rakuten-med.com (100.0%)
-
Natalie Huang
People Operations Generalist (HR)
n****g@rakuten-med.com
-
Shashank Basavaraju
Associate Manager, Technical Operations & Global Supply Chain
s*********u@rakuten-med.com
-
Carlos A Garcia
Chief Technical Officer
c*****a@rakuten-med.com
-
Unclassified inbox
info.tw@rakuten-med.com
-
Unclassified inbox
j.d@rakuten-med.com
-
General Inquiries
info@rakuten-med.com
HQ: Paris, Ile-de-France, France
Sanofi
Sanofi is a healthcare company that provides treatShow more...ments and the protection of life-saving vaccines.
HQ: Paris, Ile-de-France, France
Specialized In: Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 21, 2024
Founded Date: 1973
Number of Exits: 12
Company Type: For Profit
Stock Symbol: NYSE:SNY
Operating Status: Active
5 Emails
0 Phones
Main email format: sarah.smith@sanofi.com (66.7%)
-
Patricia Roselle
Global Head, Patient Network Management
p*************e@sanofi.com
-
Guy Griebel
Senior Director Sanofi Genzyme Neuroscience
g*********l@sanofi.com
-
Anne Dulac-Gaume
Corporate Business Development - Director
a*************e@sanofi.com
-
Unclassified inbox
caio.inbox@sanofi.com
-
Customer Service
customersupport@sanofi.com
HQ: Seattle, Washington, United States
CTI BioPharma
CTI BioPharma is a biopharmaceutical company develShow more...oping oncology products for the treatment of blood-related cancers.
HQ: Seattle, Washington, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Debt
Last Investment Activity: Jun 26, 2023
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:CTIC
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@ctibiopharma.com (100.0%)
-
Chuck Bianco
c*****o@ctibiopharma.com
-
Natalie Jaynes Brunner
Key Account Manager
n******r@ctibiopharma.com
-
patrizia angiuli
p******i@ctibiopharma.com
-
General Inquiries
medinfo@ctibiopharma.com
HQ: Silver Spring, Maryland, United States
United Therapeutics
United Therapeutics Corporation is a biotechnologyShow more... company focused on the development and commercialization of unique products.
HQ: Silver Spring, Maryland, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Last Investment Activity: Aug 28, 2024
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:UTHR
Operating Status: Active
3 Emails
0 Phones
Main email format: ssmith@unither.com (100.0%)
-
Heidi Bell
Medical Director, Medical Monitoring
h***l@unither.com
-
Nicole Wilkerson
n********n@unither.com
-
Gil PhD
Senior Vice President and Chief Medical Officer
ggolden@unither.com
-
General Inquiries
info@unither.com
HQ: Emeryville, California, United States
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled releaseShow more... combination therapeutics for infectious diseases and central nervous system disorders.
HQ: Emeryville, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Nov 24, 2021
Founded Date: 2000
Company Type: For Profit
Stock Symbol: NASDAQ:ADMS
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@adamaspharma.com (100.0%)
-
Mary Jean Stempien
VP, Clinical Research
m**********n@adamaspharma.com
-
George Gindoyan
Vice President Information Technology
g*******n@adamaspharma.com
-
David Chernoff
Chief Medical Officer
-
Vijay Shreedhar
Chief Commercial Officer
-
Investor Relations
ir@adamaspharma.com
-
General Inquiries
info@adamaspharma.com
HQ: Illkirch, Alsace, France
Domain Therapeutics
Domain Therapeutics develops small molecules targeShow more...ting G-coupled protein receptors.
HQ: Illkirch, Alsace, France
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Grant
Last Investment Activity: Mar 12, 2024
Founded Date: 2001
Company Type: For Profit
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@domaintherapeutics.com (100.0%)
-
Arturo Mancini
a******i@domaintherapeutics.com
-
Sean A. MacDonald
Chief Business Officer
s********d@domaintherapeutics.com
-
Pascal Neuville
Chief Executive Officer
-
Xavier Leroy
Chief Technology Officer
-
Stanislas leonard Malmezat
Chief Financial Officer
-
Stephan Schann
Chief Scientific Officer
-
Marjorie Sidhoum
Director of Business Operations
-
Admin Team
admin@domaintherapeutics.com
-
General Inquiries
contact@domaintherapeutics.com
HQ: San Diego, California, United States
Crinetics Pharmaceuticals
Crinetics is a clinical-stage pharmaceutical compaShow more...ny that develops therapies for people with rare endocrine diseases.
HQ: San Diego, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Founded Date: 2008
Company Type: For Profit
Stock Symbol: NASDAQ:CRNX
Operating Status: Active
6 Emails
0 Phones
Main email format: ssmith@crinetics.com (100.0%)
-
Scott Struthers
Co-Founder and CEO
s********s@crinetics.com
-
Yun-Fei Zhu
Co-Founder & Vice President, Chemistry
-
Stephen F. Betz
Vice President, Biology
-
Max Bronstein
Executive Director of Government Affairs and Patient Advocacy
-
Dana Pizzuti
Chief Development Officer
-
Alan S. Krasner
Chief Medical Officer
-
Chris Robillard
Chief Business Officer
-
Jeff Knight
COO
-
General Inquiries
info@crinetics.com
-
General Inquiries
hello@crinetics.com
-
Admin Team
admin@crinetics.com
-
Customer Service
support@crinetics.com
-
Sales Department
sales@crinetics.com
HQ: Martinsried, Bayern, Germany
MediGene
MediGene is a company that specializes in biotechnShow more...ology specifically in the treatment of cancer.
HQ: Martinsried, Bayern, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Mar 4, 2024
Founded Date: 1994
Company Type: For Profit
Stock Symbol: ETR:MDG1
Operating Status: Active
3 Emails
0 Phones
Main email format: sarah.smith@medigene.com (100.0%)
-
Pamela Keck
Vice President of Investor Relations and Corporate Communications
p*********k@medigene.com
-
James Noble
Non Executive Director
-
Gerrit Brandt
Director Accounting and Controlling
-
Dolores Schendel
Chief Scientific Officer and Managing Director
-
Investor Relations
investor@medigene.com
-
Unclassified inbox
medigene@medigene.com
HQ: Chapel Hill, North Carolina, United States
Tenax Therapeutics
Tenax Therapeutics focuses on identifying and deveShow more...loping treatments that address cardiovascular and pulmonary diseases.
HQ: Chapel Hill, North Carolina, United States
Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Feb 20, 2024
Founded Date: 1967
Company Type: For Profit
Stock Symbol: NASDAQ:TENX
Operating Status: Active
2 Emails
0 Phones
Main email format: sarah.smith@tenaxthera.com (100.0%)
-
Stuart Rich
CMO
s*********h@tenaxthera.com
-
Michael B. Jebsen
CFO
-
Eliot Lurier
Interim Chief Financial Officer
-
Chris Giordano
President & CEO
-
General Inquiries
info@tenaxthera.com
HQ: Plymouth Meeting, Pennsylvania, United States
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing tShow more...o market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
HQ: Plymouth Meeting, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 23, 2024
Founded Date: 1979
Company Type: For Profit
Stock Symbol: NASDAQ:INO
Operating Status: Active
3 Emails
0 Phones
Main email format: sarah@inovio.com (100.0%)
-
Jennifer Laux
Vice President, Marketing
j******r@inovio.com
-
Laurent Humeau
Chief Scientific Officer,Executive Vice President of Research, Engineering and Clinical Developments
-
Peter Kies
Chief Financial Officer
-
Michael Sumner
Chief Medical Officer
-
Jacqueline Shea
Chief Executive Officer
-
Paul Fisher
Director of Bioengineering
-
Shawn Bridy
Senior Vice President, Business Development
-
Unclassified inbox
jennie.willson@inovio.com
-
Unclassified inbox
ino@inovio.com
HQ: Waltham, Massachusetts, United States
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinShow more...ase inhibitor treatments.
HQ: Waltham, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:DCPH
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@deciphera.com (100.0%)
-
Philippe Teboul
p*****l@deciphera.com
-
Steven L. Hoerter
President and CEO
-
Steve Ruddy
CTO
-
Chris Morl
CBO
-
Matthew L. Sherman
EVP & CMO
-
Daniel Flynn
Founder and Chief Scientific Officer
-
Tucker P. Kelly
EVP & Chief Financial Officer
-
General Inquiries
info@deciphera.com
-
Unclassified inbox
lkiniklis@deciphera.com
-
Unclassified inbox
medicalinformation@deciphera.com
HQ: Wadenswil, Zurich, Switzerland
Numab
Numab is a biotechnology company that offers antibShow more...ody-based therapeutics for the treatment of severe diseases.
HQ: Wadenswil, Zurich, Switzerland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Series C
Last Investment Activity: Feb 13, 2024
Founded Date: 2011
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
4 Emails
1 Phones
Main email format: s.smith@numab.com (100.0%)
-
David Urech
CSO, and Co-CEO, Founder
d*****h@numab.com
T***********************************************************************************m
-
Oliver Middendorp
CBO, Co-CEO, and Co-Founder
-
Peter Lichtlen
CMO and Co-Founder
-
Tea Gunde
Head of Pharmacology
-
Sebastian Meyer
Chief Operating Officer
-
Roland Helfenstein
Chief Financial Officer
-
General Inquiries
info@numab.com
-
Admin Team
admin@numab.com
-
Legal Department
legal@numab.com
HQ: Oxford, Oxfordshire, United Kingdom
Vaccitech
Vaccitech is creating novel vaccines that elicit sShow more...trong responses from helper and cytotoxic T-cells.
HQ: Oxford, Oxfordshire, United Kingdom
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 101-250
Rounds: Series B
Last Investment Activity: Nov 6, 2023
Founded Date: 2016
Company Type: For Profit
Stock Symbol: NASDAQ:VACC
Operating Status: Active
6 Emails
1 Phones
Main email format: sarah.smith@vaccitech.co.uk (100.0%)
-
Meg Marshall
CMO
m**********l@vaccitech.co.uk
T*******************************************************************k
-
Sarah Gilbert
Co-Founder & Professor of Vaccinology
-
Georgy Egorov
CFO
-
Graham Griffiths
Chief Business Officer
-
Nadege Pelletier
Chief Scientific Officer
-
Thomas Evans
consultant
-
Chris Ellis
Chief Operating Officer
-
Malkit Sami
Associate Director
-
Investor Relations
ir@vaccitech.co.uk
-
Enquiries
enquiries@vaccitech.co.uk
-
Unclassified inbox
henry.hodge@vaccitech.co.uk
-
Unclassified inbox
karim.saleh@vaccitech.co.uk
-
General Inquiries
info@vaccitech.co.uk
HQ: Paris, Ile-de-France, France
HRA Pharma
HRA Pharma develops and sells reproductive health Show more...drugs, devices, and services to patients
HQ: Paris, Ile-de-France, France
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Private Equity
Last Investment Activity: Jul 10, 2024
Founded Date: 1996
Company Type: For Profit
Operating Status: Active
2 Emails
0 Phones
Main email format: s.smith@hra-pharma.com (100.0%)
-
Francois Durin
Licensing & Alliance Management Director
f*****n@hra-pharma.com
-
Martyn Hilton
Chief Global Commercial Officer
-
David Wright
Chief Executive Officer
-
Geoff Allan
CFO
-
Paul Carter
Chief Scientific Officer
-
Sophie Lacourrège
Chief Human Resources & Communication Officer
-
Florian Battung
Chief Corporate Development & Strategy Officer
-
Unclassified inbox
careers@hra-pharma.com
HQ: Maryland, Louisiana, United States
MedImmune
MedImmune develops medicines for unmet medical neeShow more...ds worldwide.
HQ: Maryland, Louisiana, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Acquired by: AstraZeneca
Business Type: Private
Employees: 5001-10000
Last Investment Activity: Aug 30, 2023
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed
4 Emails
0 Phones
Main email format: sarahs@medimmune.com (100.0%)
-
Venkat Raghavan
v*****r@medimmune.com
-
Rakesh Dixit
Vice President, R & D, Global Head, Biologics Safety Assessment
-
Ed Mathers
Executive Vice President, Corporate Development and Venture
-
Frank J. Malinoski
Team Member
-
James Brown
Director, IT Relationship Management, R&D
-
Admin Team
admin@medimmune.com
-
Customer Service
support@medimmune.com
-
Sales Department
sales@medimmune.com
HQ: Maryland, Louisiana, United States
MedImmune
MedImmune develops medicines for unmet medical neeShow more...ds worldwide.
HQ: Maryland, Louisiana, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Acquired by: AstraZeneca
Business Type: Private
Employees: 5001-10000
Last Investment Activity: Aug 30, 2023
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed
4 Emails
0 Phones
Main email format: sarahs@medimmune.com (100.0%)
-
Venkat Raghavan
v*****r@medimmune.com
-
Admin Team
admin@medimmune.com
-
Customer Service
support@medimmune.com
-
Sales Department
sales@medimmune.com
HQ: Planegg, Bayern, Germany
4SC
4SC discovers and develops targeted, small-moleculShow more...e drugs for the treatment of cancer and autoimmune diseases.
HQ: Planegg, Bayern, Germany
Specialized In: Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Mar 22, 2024
Founded Date: 1997
Company Type: For Profit
Stock Symbol: FRA:VSC
Operating Status: Active
4 Emails
0 Phones
-
Jason Loveridge
Chief Executive Officer
-
Susanne Danhauser-Riedl
Chief Medical Officer
-
Frank Hermann
Chief Development Officer
-
Unclassified inbox
public@4sc.com
-
Unclassified inbox
ir-pr@4sc.com
-
General Inquiries
info@4sc.com
-
Unclassified inbox
ursula.herz@4sc.com
HQ: San Diego, California, United States
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a neuro-biotechnology coShow more...mpany developing treatments for neuro-based disorders.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Aug 4, 2023
Founded Date: 2006
Company Type: For Profit
Stock Symbol: NASDAQ:ADMP
Operating Status: Active
1 Emails
0 Phones
-
Dennis J. Carlo
Founder & CEO
-
David C. Benedicto
Chief Financial Officer
-
General Inquiries
info@adamispharma.com
HQ: Houston, Texas, United States
ImmunoMet Therapeutics
ImmunoMet Therapeutics is a biopharmaceutical compShow more...any that develops and commercializes oncology products for cancer patients.
HQ: Houston, Texas, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Series B
Last Investment Activity: Jul 26, 2021
Founded Date: 2015
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Edward Garmey
Consultant CMO
-
Sungwuk Kim
CEO
-
Revati Shreeniwas
Chief Medical Officer
-
General Inquiries
info@immunomet.com
HQ: Cambridge, Cambridgeshire, United Kingdom
Phico Therapeutics
Phico Therapeutics is a developer of novel platforShow more...m technology designed to overcome antibacterial resistance.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Venture - Series Unknown
Last Investment Activity: Feb 1, 2022
Founded Date: 2000
Company Type: For Profit
Operating Status: Active
3 Emails
0 Phones
-
Heather Fairhead
Founder & CEO
-
Katy Pitts
Facility manager and senior R&D scientist
-
James Cass
Manager of research and development
-
Anthony Martin
Chairman & Non Executive Director
-
General Inquiries
info@phicotx.co.uk
-
Admin Team
admin@phicotx.co.uk
-
General Inquiries
info@phicotherapeutics.co.uk
HQ: Vancouver, British Columbia, Canada
Novelion Therapeutics
Novelion Therapeutics Inc, formerly QLT Inc., is aShow more... Canada-based biopharmaceutical company
HQ: Vancouver, British Columbia, Canada
Specialized In: Pharmaceuticals, Biotechnology, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Aug 25, 2021
Founded Date: 1981
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NVLN
Operating Status: Active
1 Emails
0 Phones
-
Robert L. Butchofsky
President & CEO
-
Cameron R. Nelson
CFO
-
Investor Relations
ir@qltinc.com
HQ: Beijing, Beijing, China
Sinovac Biotech
Sinovac Biotech Ltd. is a China-based biopharmaceuShow more...tical company that focuses on research, development, manufacturing and commercialization
HQ: Beijing, Beijing, China
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Delisted
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Apr 26, 2024
Founded Date: 2001
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SVA
Operating Status: Active
1 Emails
0 Phones
-
Weidong Yin
Founder & CEO
-
Nan Wang
Vice President, Business Development
-
Unclassified inbox
sinovac@sinovac.com
HQ: Wilmington, North Carolina, United States
PPD clinical research business of Thermo Fisher Scientific
The PPD clinical research business of Thermo FisheShow more...r Scientific offers CRO services, including clinical development and analytical solutions.
HQ: Wilmington, North Carolina, United States
Specialized In: Biotechnology, Coaching & Consulting, Healthcare & Medical, Medical Devices, Pharmaceuticals, Hospitals & Clinics
Acquired by: Thermo Fisher Scientific
Business Type: Delisted
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Apr 24, 2024
Founded Date: 1985
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:PPD
Operating Status: Active
1 Emails
0 Phones
-
Kimberly Kasprowicz
Sr. Clinical Team Manager
-
Mark Corrigan
Associate Group Leader
-
Brent Reed
Director of IT
-
Duu-Gong Wu
Senior Director, Regulatory and Technical Advisors, Global Regulatory Affairs,
-
Andy Strayer
Vice President
-
Peter Wyld
Vice President, Onocology and Haematology Global Product Development
-
Ronald (Ron) Garrow
Executive Vice President, Chief Human Resources Officer
-
Claire Nickols
Director, Project Oversight, Haematology & Oncology, Global Project Management
-
Unclassified inbox
dpo.sm@ppd.com
HQ: Clermont-ferrand, Auvergne, France
Laboratoires Théa
Laboratoires Thea is an independent pharmaceuticalShow more... company specialized in research,development and commercialization of eyecare products.
HQ: Clermont-ferrand, Auvergne, France
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 501-1000
Last Investment Activity: Jan 31, 2024
Founded Date: 1993
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Fabrice Mercier
Alliance Manager
-
Susan Benton
President, USA
-
Henri Chibret
Founder
-
Marketing Team
globalmarketing@laboratoires-thea.fr
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.